Literature DB >> 20879750

“Locked onto the target”: increasing the efficiency of antagomirzymes using locked nucleic acid modifications.

Harleen Kaur1, Vinod Scaria, Souvik Maiti.   

Abstract

This study highlights the effect of incorporation of locked nucleic acid (LNA) on improving the functional efficacy of DNAzymes against microRNAs (antagomirzymes). DNAzymes were designed against two different sites of miR-27a, which were encompassed both within the precursor and mature form of miRNA. The cleavage and functional activities of these DNAzymes have been compared to those of LNA-modified counterparts, containing LNA modification in each of the substrate binding arms. Preliminary examination based on in vitro cleavage demonstrated LNAzyme to be much more effective in the ensuing cleavage of target miRNA under both single- and multiple-turnover conditions. Evaluation of kinetic parameters indicated almost 5-fold higher cleavage efficiency, kobs, for LNAzymes than for DNAzymes, leading to more efficient cleavage of the substrate. We attribute this enhancement in cleavage efficiency to the LNA-mediated improvement in the hybridization of the antagomirzyme·target complex. Functional validation of the relative activities was accomplished through the luciferase reporter assay and quantitative real-time polymerase chain reaction (qRT-PCR). Both the unmodified and LNA-modified antagomirzymes were very active in ensuing efficient miRNA knockdown; however, compared to the DNAzymes, the LNAzymes were almost 25% more active. A direct quantitative estimate of miRNA cleavage, conducted using qRT-PCR, further substantiated the data by indicating that LNAzyme effectively downregulated the levels of mature miRNA (up to 50%) versus the corresponding DNAzymes. Our data thus provide formative evidence of the successful employment of LNA-based antagomirzymes against miRNA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20879750     DOI: 10.1021/bi101185k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  HDL and microRNA therapeutics in cardiovascular disease.

Authors:  Danielle L Michell; Kasey C Vickers
Journal:  Pharmacol Ther       Date:  2016-09-03       Impact factor: 12.310

2.  A modular XNAzyme cleaves long, structured RNAs under physiological conditions and enables allele-specific gene silencing.

Authors:  Alexander I Taylor; Christopher J K Wan; Maria J Donde; Sew-Yeu Peak-Chew; Philipp Holliger
Journal:  Nat Chem       Date:  2022-09-05       Impact factor: 24.274

Review 3.  Coupling Aptamers to Short Interfering RNAs as Therapeutics.

Authors:  Laura Cerchia; Carla Lucia Esposito; Simona Camorani; Silvia Catuogno; Vittorio de Franciscis
Journal:  Pharmaceuticals (Basel)       Date:  2011-10-27

4.  Locked and unlocked nucleosides in functional nucleic acids.

Authors:  Holger Doessing; Birte Vester
Journal:  Molecules       Date:  2011-05-27       Impact factor: 4.411

5.  One-step isothermal RNA detection with LNA-modified MNAzymes chaperoned by cationic copolymer.

Authors:  Orakan Hanpanich; Ken Saito; Naohiko Shimada; Atsushi Maruyama
Journal:  Biosens Bioelectron       Date:  2020-06-12       Impact factor: 10.618

6.  Targeting non-coding RNA family members with artificial endonuclease XNAzymes.

Authors:  Maria J Donde; Adam M Rochussen; Saksham Kapoor; Alexander I Taylor
Journal:  Commun Biol       Date:  2022-09-24

7.  Potent inhibition of miR-27a by neomycin-bisbenzimidazole conjugates.

Authors:  Smita Nahar; Nihar Ranjan; Arjun Ray; Dev P Arya; Souvik Maiti
Journal:  Chem Sci       Date:  2015-07-09       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.